We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Growing Need for IT in Life Sciences

By Biotechdaily staff writers
Posted on 21 Dec 2005
The growth of data and the need for regulatory compliance are driving expenditures for information technology (IT) in the life sciences. More...
Total IT world-wide spending is forecast to reach U.S.$49.30 billion in 2011, compared to $17.10 billion in 2004, according to a new report from Frost & Sullivan (Palo Alto, CA, USA).

Surging volumes of data in the life sciences industry have created a challenge for scientists who must collect and analyze them. In spite of the fact that life science companies have large repositories of paper-based data, there is a high market potential for IT vendors in digitizing, storing, and managing this data throughout its life cycle. Companies are also realizing the importance of combining data from various locations and storing it in a central warehouse.

"The life science industry is now in a period of transition, as it seeks to use IT to resolve the process inefficiencies that cause a lot of dollars to be wasted across the spectrum, from R&D to post-marketing,” noted Raghavendra Chitta, an industry analyst with Frost & Sullivan.

IT is proving to be a key tool in helping companies communicate regulatory requirements across business areas. Recent market withdrawals of drugs have created an increased focus on pharmacovigilance and related regulatory compliance. While big pharmaceutical companies hold potential for IT vendors because of their more mature, predictable, and large IT budgets, they are more complex customers. Drug recalls and pricing pressures have resulted in the rationalization of operational costs. The larger drug companies have already replaced legacy systems, leaving little chance for increased IT spending.

As a result, the entire selling structure in the life sciences is moving towards value-based selling and tools in the industry that generate value. IT companies, therefore, have to develop return-on-investment (ROI) models and provide proof for these values. At the same time, developing new tools that are capable, interoperative, and can run on existing infrastructure--offering customizing, consulting services, and easy integration--will also be critical to success.






Related Links:
Frost & Sullivan

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer cells (red) stick to mesothelial cells (green) and form hybrid spheres that cut into surrounding abdominal tissue (Photo courtesy of Uno et al., 2026)

Abdominal Fluid Testing Can Predict Ovarian Cancer Progression

Ovarian cancer kills more women than any other gynecological cancer, largely because it is usually diagnosed only after it has spread widely within the abdomen. Unlike many other cancers, it does not rely... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.